Can heart rate variability parameters derived by a heart rate monitor differentiate between atrial fibrillation and sinus rhythm? by Broux, Barbara et al.
RESEARCH ARTICLE Open Access
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differentiate between atrial fibrillation
and sinus rhythm?
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Abstract
Background: Heart rate variability (HRV) parameters, and especially RMSSD (root mean squared successive
differences in RR interval), could distinguish atrial fibrillation (AF) from sinus rhythm(SR) in horses, as was
demonstrated in a previous study. If heart rate monitors (HRM) automatically calculating RMSSD could also
distinguish AF from SR, they would be useful for the monitoring of AF recurrence. The objective of the study was
to assess whether RMSSD values obtained from a HRM can differentiate AF from SR in horses. Furthermore, the
impact of artifact correction algorithms, integrated in the analyses software for HRV analyses was evaluated.
Fourteen horses presented for AF treatment were simultaneously equipped with a HRM and an electrocardiogram
(ECG). A two-minute recording at rest, walk and trot, before and after cardioversion, was obtained. RR intervals used
were those determined automatically by the HRM and by the equine ECG analysis software, and those obtained
after manual correction of QRS detection within the ECG software. RMSSD was calculated by the HRM software and
by dedicated HRV software, using six different artifact filters. Statistical analysis was performed using the Wilcoxon
signed-rank test and receiver operating curves.
Results: The HRM, which applies a low level filter, produced high area under the curve (AUC) (> 0.9) and cut off
values with high sensitivity and specificity. Similar results were obtained for the ECG, when low level artifact filtering
was applied. When no artifact correction was used during trotting, an important decrease in AUC (0.75) occurred.
Conclusion: In horses treated for AF, HRMs with automatic RMSSD calculations distinguish between AF and SR.
Such devices might be a useful aid to monitor for AF recurrence in horses.
Keywords: Arrhythmia, Artifact correction, Cardioversion, Equine
Introduction
With a prevalence of 0.3–2.5% of the population, atrial
fibrillation (AF) is the most common clinically important
arrhythmia in horses. Treatment, either by pharmaco-
logical or electrical cardioversion, is often successful, but
recurrence rates are reported to be relatively high (16–43%)
[1–5]. Most horses with AF have little or no detectable
underlying cardiac diseases and clinical signs limited to
different grades of poor performance. During strenuous
exercise horses with AF can reach extremely high heart
rates which may lead to R-on-T phenomenon and, in rare
cases, even collapse or sudden death [6–8]. Timely diagno-
sis and treatment are important. After successful AF treat-
ment, home monitoring by means of frequent auscultation
or ECG is advised to check for AF recurrence. However,
this cannot always be performed by lay people, requiring
frequent veterinary visits or specialized equipment, which is
time consuming and expensive.
Heart rate variability (HRV) describes and quantifies
the beat-to-beat variability and the long-term variation
in heart rate [9]. The heart rate is influenced by both the
autonomic nervous system and the neuroendocrine
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system. Cyclical and beat-to-beat variations in heart rate
are normal in the healthy individual. In horses, HRV has
been used to study the autonomic regulation of the heart
and animal welfare, quantifying stress and pain [10–12].
Aside from its use as indicator of autonomic tone, HRV is
used in human medicine to diagnose arrhythmias [13, 14].
Since arrhythmia, especially AF, leads to an increased
beat-to-beat interval variation, HRV parameters de-
scribing short-term variability are increased compared
to sinus rhythm (SR) and algorithms using HRV pa-
rameters are implemented in devices detecting AF in
humans [15–19]. In horses, HRV has already been
evaluated for the detection of AF in horses before and
after transvenous electrical cardioversion [20]. In that
study, 6 different HRV variables were calculated from
RR intervals after beat-to-beat QRS identification on the
ECG trace, both during AF and during SR. RMSSD, the
root mean squared successive differences in RR interval,
yielded the best results with high sensitivity and specificity
to distinguish AF from SR.
Different types of heart rate monitors (HRM) are in-
creasingly being used in horses and some of them offer
basic HRV calculations, including RMSSD [11, 21, 22].
They might be an accessible diagnostic tool for both
veterinarians and horse owners to monitor horses for AF
recurrence. Most HRMs, however, have not been vali-
dated for use in horses and significant differences be-
tween their RR registration and RR intervals from ECG
recordings have been shown [23]. Therefore the purpose
of this study was to assess whether AF and SR can be
differentiated in horses based upon RMSSD generated
from a HRM or automatically analyzed ECG trace, using
that from manually identified RR intervals from an ECG
as gold standard. Furthermore the impact of artifact
correction prior to HRV analysis was evaluated.
Materials and methods
Study design and study population
Fourteen warmblood horses were presented to the Fac-
ulty of Veterinary Medicine, Ghent University for the
treatment of AF. All horses were client-owned horses
admitted to our clinic for cardiac examination and
treatment of AF. AF was confirmed in all horses by an
experienced cardiologist using an ambulatory ECG
recording. All horses were warmblood horses with a
mean ± SD age, bodyweight and height at the withers
of 12 ± 6 years, 544 ± 62 kg and 167 ± 13 cm. The study
population consisted of 5 mares, 8 geldings and 1 stallion.
All horses were included in the study with written in-
formed owner consent and cared for according to the
principles outlined in the NIH Guide for the Care and Use
of Laboratory Animals. Each horse was simultaneously
equipped with a HRM and an ECG and subjected to a re-
cording at rest and a standardized exercise test including
5 min of walk and 10 min of trot, both in AF (before car-
dioversion) and in SR (5 days after cardioversion). The
recordings of both devices was started at the same time.
After the examinations and AF treatment, all horses
returned home with the owners.
Electrodes and heart rate detection
Three different systems of heart rate detection (elec-
trodes + RR detection) were compared. A modified base
apex ECG was recorded as described elsewhere [20], using
adhesive electrodes (Skintact, Leonhard Lang GmbH, Inns-
bruck, Austria) and analyzed using a commercial ECG soft-
ware program (Televet 100 software version 5.1.2, Engel
Engineering Services GmbH, Heusenstamm, Germany)
with a detection limit of 8%, meaning that all RR intervals
differing more than 8% from the previous RR interval were
detected as outliers, but included in the analysis. First, the
RR intervals automatically detected by the ECG software,
leaving errors in QRS detection in place, were exported
(ECGAut). Subsequently, all RR intervals were checked by
one experienced observer and manually corrected within
the software in case of artifacts or wrong QRS detection to
obtain manually corrected RR intervals (ECGMan) which
served as gold standard. Furthermore, a HRM using a com-
mercial plastic electrode set (Polar equine heart rate elec-
trode set, Polar Electro Benelux, Dendermonde, Belgium)
and a heart rate sensor for RR detection (Polar heart rate
sensor H7, Polar Electro Benelux, Dendermonde, Belgium)
was attached according to the manufacturer’s instructions.
Also for this detection method, errors in RR detection by
the HRM were left in the database.
Heart rate variability and artifact correction methods
From all 14 horses, RR intervals from both ECGMan and
ECGAut were imported in Kubios Software (Kubios Heart
Rate Variability Analysis Software, Varsitie 22, 70,150 Kuopio,
Finland) at default settings (smooth priors and Lambda
500) for HRV analysis, while RR data from the HRM
were imported into its own commercial software program
(Polar Flow Software, Polar Electro Benelux, Dender-
monde, Belgium) (Table 1). Subsequently, a time-matched
2-min recording at rest, walk and trot, both in AF and SR,
was selected for calculation of RMSSD using the following
formula:
RMSSD ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
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Each recording was obtained 2 min after a change in
gait, in order to exclude movement artifacts and stress
reactions from the gait change.
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Furthermore, for the ECGAut method, within the Kubios
HRV software program, 5 different levels of artifact correc-
tion were applied. The artifact correction algorithm of this
program compares every RR interval value against the aver-
age RR interval of the 2-min recording. The average is ob-
tained by median filtering of the RR interval time series,
and is therefore not affected by single outliers in RR interval
time series. RR intervals that differ from the local average
more than a specified threshold value, are identified as
artifacts and corrected by replacing them by interpolated
RR values using a cubic spline interpolation. The threshold
values used in this study were 0.45 s (very low artifact cor-
rection; values that differ more than 0.45 s from the aver-
age), 0.35 s (low), 0.25 s (moderate), 0.15 s (high) and 0.05 s
(very high). For example, the “Medium” correction level will
identify all RR intervals that are 0.25 s longer/shorter
compared to the local average. Detailed information about
filtering methods is free available online in the Kubios user
manual. For the ECGMan method, no artifact correction
was applied, while the commercial software program used
for the RR intervals obtained with the HRM method, uses
its own, unknown artifact correction algorithm.
Statistical analysis
Statistical analysis was performed using dedicated software
(SPSS 24, IBM Analytics, Brussels, Belgium). Descriptive
statistics, quantile-quantile plots and Shapiro-Wilk tests
were used to check for normality of data.
Data were not normally distributed and therefore non-
parametric related samples Wilcoxon signed-rank tests
were used to detect significant differences in RMSSD be-
tween horses in AF and SR at different paces using the
Table 1 Median and range of the RMSSD values of 14 horses before (in atrial fibrillation (AF)) and after cardioversion (in sinus rhythm (SR))
Pace Method Artifact
correction
RMSSD AF RMSSD SR P-value
Median Range Median Range
Rest ECGMan none 670 248–1409 85 26–378 0.024*
Rest ECGAut none 674 244–1409 118 26–580 0.024*
Rest ECGAut Kubios very low 216 194–293 87 26–181 .0.024*
Rest ECGAut Kubios low 195 160–233 82 16–175 0.024*
Rest ECGAut Kubios moderate 145 125–193 72 26–145 0.024*
Rest ECGAut Kubios high 78 61–112 61 25–94 0,79
Rest ECGAut Kubios very high 23 13–98 30 18–56 1
Rest HRM Polar Flow 233 72–329 78 32–169 0.024*
Walk ECGMan None 229 84–495 43 11–185 0.024*
Walk ECGAut None 226 153–495 83 11–194 0.024*
Walk ECGAut Kubios very low 189 124–236 34 11–113 0.024*
Walk ECGAut Kubios low 163 117–219 34 11–104 0.024*
Walk ECGAut Kubios moderate 135 105–161 34 11–79 0.024*
Walk ECGAut Kubios high 82 62–102 28 11–63 0.024*
Walk ECGAut Kubios very high 33 11–52 22 10–45 1
Walk HRM Polar Flow 126 49–167 32 6–73 0.024*
Trot ECGMan None 89 53–144 10 5–18 0.024*
Trot ECGAut None 125 34–377 86 7–221 1
Trot ECGAut Kubios very low 93 52–187 13 7–58 0.024*
Trot ECGAut Kubios low 84 48–124 13 7–53 0.024*
Trot ECGAut Kubios moderate 71 43–122 13 7–36 0.024*
Trot ECGAut Kubios high 52 34–85 13 7–32 0.024*
Trot ECGAut Kubios very high 22 14–49 11 5–32 0,22
Trot HRM Polar Flow 37 25–108 6 5–16 0.024*
Two-minute recordings at rest, walk and trot were analyzed using 4 different methods of RR detection and HRV analysis. The automatically analyzed ECG followed
by beat-to-beat manual correction of QRS detection (ECGMan) with HRV analysis using Kubios HRV Software without artifact filter was considered the gold
standard method. HRM Polar heart rate monitor (Equine H7) with plastic electrodes and Polar Flow Software. ECGAut ECG with automatic RR interval detection
(Televet 100) and Kubios HRV software with 5 different artifact correction levels. The artifact correction algorithm identifies every RR interval that differs from the
average RR interval of the 2-min recording more than a specified threshold value as artifacts and replaces the corrupted RR interval by interpolated RR values. The
threshold values used in this study were 0.45 s (very low artifact correction), 0.35 s (low), 0.25 s (moderate), 0.15 s (high) and 0.05 s (very high). * Indicates
significant differences
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different detection methods and artifact correction levels.
Bonferroni corrections were applied to account for mul-
tiple (× 24) comparisons. Receiver operating characteristic
(ROC) curves were used to study the performance of each
method and each artifact correction level as a discrim-
inatory variable for the detection of AF. The coordinate
points of the ROC curves were used to determine the
most fitting cut off values for each parameter at each
recording. Cut off values were chosen to maximize sen-
sitivity whilst retaining good (≥80%) specificity, where
possible.
Results
Mean values for RMSSD are displayed in Table 1.
RMSSD values obtained from the ECG were significantly
different (P < 0.05) between horses in SR and horses in
AF, except when a high level of artifact correction was
used and at trot if no artifact correction was applied.
RMSSD values obtained with the HRM were signifi-
cantly different between horses in SR and horses in AF,
at all paces.
AUCs, cut off values and their sensitivity and specifi-
city for the use of RMSSD as a discriminatory variable
for the detection of atrial fibrillation are displayed in
Table 2. Using the Polar Flow software in combination
with a plastic electrode set (HRM), led to reliable cut
off values, especially during exercise. ECGAut, without
artifact correction, led to reliable results at rest and
at walk (AUC 0.96), but there was an important de-
crease in AUCs during trotting exercise (AUC 0.75).
Low level artifact correction during trotting exercise,
led to a clear improvement in AUC (=1) and cut off
values with very high sensitivity and specificity. High
levels of artifact correction resulted in an important
Table 2 Area under the curve (AUC), cut off values and their sensitivity and specificity, and 95% confidence intervals (95% CI) for the
use of RMSSD as discriminatory variable to distinguish atrial fibrillation from sinus rhythm in 14 warmblood horses
Pace Method Artifact
correction
AUC cut
off
sens spec
95% CI 95% CI
Rest ECGMan none 0.99 215 1 0.77–1 1 0.77–1
Rest ECGAut none 0.96 383 0.93 0.66–1 0.93 0.66–1
Rest ECGAut 1 1 188 1 0.77–1 1 0.77–1
Rest ECGAut 2 0.99 131 1 0.66–1 0.93 0.66–1
Rest ECGAut 3 0.94 111 1 0.77–1 0.93 0.66–1
Rest ECGAut 4 0.77 65 0.93 0.66–1 0.69 0.42–0.92
Rest ECGAut 5 0.37 24 0,5 0.23–0.77 0.38 0.13–0.65
Rest HRMElec Polar Flow 0.93 136 0.86 0.57–0.98 0.86 0.57–0.98
Walk ECGMan none 0.97 121 0.93 0.66–1 0.93 0.66–1
Walk ECGAut none 0.96 164 0.93 0.66–1 0,86 0.57–0.98
Walk ECGAut 1 1 119 1 0.77–1 1 0.77–1
Walk ECGAut 2 1 111 1 0.77–1 1 0.77–1
Walk ECGAut 3 1 92 1 0.77–1 1 0.77–1
Walk ECGAut 4 0.99 57 1 0.77–1 0.93 0.66–1
Walk ECGAut 5 0.74 22 0.78 0.49–0.95 0.57 0.29–0.82
Walk HRMElec Polar Flow 0.97 70 0.93 0.66–1 0.93 0.66–1
Trot ECGMan none 1 36 1 0.77–1 1 0.77–1
Trot ECGAut none 0.77 90 0.86 0.57–0.98 0.72 0.42–0.91
Trot ECGAut 1 1 51 1 0.77–1 0.93 0.66–1
Trot ECGAut 2 1 42 1 0.77–1 0.93 0.66–1
Trot ECGAut 3 1 40 1 0.77–1 1 0.77–1
Trot ECGAut 4 1 33 1 0.77–1 1 0.77–1
Trot ECGAut 5 0.93 15 0.93 0.66–1 0.93 0.66–1
Trot HRMElec Polar Flow 1 21 1 0.77–1 1 0.77–1
Two-minute recordings at rest, walk and trot were analyzed using 4 different methods of RR detection and HRV analysis. The automatically analyzed ECG followed
by beat-to-beat manual correction of QRS detection (ECGMan) with HRV analysis using Kubios HRV Software was considered the gold standard method. HRM Polar
heart rate monitor (Equine H7) with plastic electrodes and Polar Flow Software. ECGAut ECG with automatic RR interval detection (Televet 100) and Kubios HRV
software with 5 different artifact correction levels. The artifact correction algorithm identifies every RR interval that differs from the average RR interval of the 2-
min recording more than a specified threshold value as artifacts and replaces the corrupted RR interval by interpolated RR values. The threshold values used in
this study were 0.45 s (very low artifact correction), 0.35 s (low), 0.25 s (moderate), 0.15 s (high) and 0.05 s (very high)
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drop in AUCs, especially at rest. Receiver operating curves
(ROC) are available as Additional file 1.
Discussion
The goal of our study was to assess an easily applicable
tool for home monitoring of AF recurrence after treat-
ment. In the current study pre-treatment AF could be
differentiated from post-treatment SR based upon
RMSSD using a commercially available HRM. Investiga-
tion of different artifact filtering levels showed that,
compared to no filtering, low levels of artifact correction
improved sensitivity and specificity, especially during
trotting exercise. However, sensitivity and specificity fell
with higher levels of filtering.
In this study RMSSD was chosen as the HRV parameter
to distinguish AF from SR. RMSSD is a time domain HRV
parameter and especially useful in assessing short term
HRV [9, 24]. In a previous study, using 6 different HRV
parameters for the differentiation between AF and SR in
horses, RMSSD yielded the best results with cut off values
with high sensitivity and specificity, identifying all cases of
AF with only a small chance of false positives [20]. Fur-
thermore, RMSSD is a well-known and frequently used
HRV parameter, available on a variety of HRMs, HRV soft-
ware programs and mobile applications, which could
make it a suitable tool for home monitoring of AF recur-
rence after treatment. However, if RMSSD calculations are
not available, SDNN (the standard deviation of the RR
intervals) and SD1 (nonlinear parameter, derived from
Poincaré plot), other frequently used HRV parameters
and inter-related with RMSSD, might also be useful
to detect AF [20].
Correct QRS detection is important to obtain correct
RR intervals but the algorithms used by devices is often
unknown. Filtering of data is often used to eliminate
erroneously detected artifacts from the dataset before
RMSSD is calculated. Several methods to record RR in-
tervals were used in this study. Automatic analysis
followed by manual correction of identified QRS com-
plexes of an ECG trace using adhesive electrodes and
calculation of RMSSD by specialized software without fil-
tering was used as gold standard. However, this requires
specialized equipment, expertise for ECG interpretation
and data handling (exporting, importing), which is time
consuming and expensive. Automatic analysis of the ECG
trace by dedicated software reduces analysis time, but also
introduces error. HRMs are increasingly being used by
both veterinarians and horse owners, because they are
relatively cheap and easy to use. They automatically detect
heart rate and some devices also generate HRV calcula-
tions, including RMSSD. Previous studies assessing preci-
sion and accuracy of HRMs both in horses and in other
animals, however, reported variable results and many
HRMs have not been thoroughly validated in horses
[23, 25–28]. Furthermore, different HRMs with differ-
ent electrode design and RR detection software are
available. Although in our study the ECG and HRM re-
cordings were started exactly at the same time, the HRM
recording appeared to show a lag and therefore our data
did not allow to evaluate the performance of HRMs in cor-
rectly detecting individual QRS complexes. Since large dif-
ferences in RMSSD between horses in AF and in SR have
been shown [20], we hypothesized that, even if the use of a
HRM introduced some error in RR detection, differences
were sufficiently large to allow for reliable differentiation.
For the data obtained by the HRM, we used Polar Flow
commercial software for HRV analysis. There are, however,
numerous other, often cheaper, software programs and
mobile phone applications available automatically import-
ing RR data from HRMs via Bluetooth, displaying them in
real time and immediately generating some basic HRV cal-
culations. These applications might be useful candidates
for home monitoring of horses at risk for AF recurrence
but need to be validated.
Different HRV software programs might apply a differ-
ent artifact correction method. The second goal of this
study was to assess the effect of artifact correction levels
on RMSSD as a discriminatory parameter for the AF de-
tection. Artifact filters eliminate outliers, i.e. RR intervals
that strongly differ from other RR intervals, by deleting
them or replacing them by interpolated values. Although
this filtering helps to delete artifacts, it will also blunt
beat-to-beat variation which is typical for AF. Low level
artifact correction resulted in improved sensitivity and
specificity approaching 100% at all paces. During SR,
second degree atrioventricular block (AVB) is a common
finding in horses at rest with a large impact on HRV
[29]. In our study, low level artifact correction probably
eliminated most AVB from the analysis, since AVB leads
to a very large increase in RR interval, and may be im-
portant in distinguishing AF from SR with frequent
AVB. The Polar Flow software also uses an algorithm for
artifact correction, which cannot be adapted. Unfortu-
nately the authors were not able to obtain the details of
this algorithm, but mean Polar values were close to
mean Kubios values after Low to Moderate filtering. We
have chosen to use the Kubios software because it is
often used in human and veterinary medicine, it is free
online available, and it allows to apply different filter
levels. Our data suggest that low level filtering is needed,
but that higher filter levels decrease specificity and sensi-
tivity. We tested a limited number of filters only and
cannot conclude upon the optimal filter. A large number
of HRV analysis software programs are commercially
available but one should be aware that each of them uses
its own, usually unknown, QRS detection algorithm
and type of filtering, which may have a big effect on
the obtained RMSSD value.
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In human medicine, artifact correction algorithms are also
used in AF detection devices [16, 17, 30]. Reported sensitiv-
ity and specificity of these human devices range from 86.6–
100% and 84.3–99.9%, respectively [15, 18, 19, 30].
Cut off values determined in this study were chosen
to optimize sensitivity whilst maintaining good specifi-
city. Because early diagnosis positively affects outcome
and AF may occasionally be associated with dangerous
ventricular tachyarrhythmias, our focus was to identify
all horses with AF, even if this potentially included
some false positives. False positives, however, will
most likely arise from either incorrect RR registration,
electrical interference and movement artifacts, or from
horses with frequent arrhythmias other than AF. If
these horses remain positive at consecutive HRM ses-
sions during walk and trot, further electrocardio-
graphic examination is indicated as other arrhythmias
might be present.
Despite the relatively small study population and the
unknown level of error introduced by the heart rate
detection method of the HRM, differences in HRV be-
tween SR and AF were large, leading to reliable cut off
values. Also, power calculations based upon RMSSD dif-
ferences between horses in AF and in SR from a previ-
ous study [20], indicated sufficient power to detect
significant differences with 5–7 horses. An important
limitation of the study was its self-control design. We
used horses before and after cardioversion since our goal
was to differentiate AF from SR after successful treat-
ment. Atrial premature depolarizations were often found
post-cardioversion in these horses which could poten-
tially make differentiation more challenging than if a
control group of normal horses had been used. In this
study we did not specify the number of arrhythmias but
our previous study already showed that a high number
of AVB during SR has an important effect on RMSSD,
while a high number of atrial premature depolarization
has not. We did not include horses with other arrhyth-
mias than AVB and atrial premature depolarizations in
this study and it remains to be proven whether this tech-
nique can also be used to diagnose AF in a random
population of horses.
Conclusions
We conclude that in horses before and after TVEC,
AF can be differentiated from SR using RMSSD values
obtained from automatically analyzed ECGs but also
from an equine HRM. One should be aware that heart
rate detection technique as well as level of artifact
correction are important. Since we did not include
horses with other arrhythmias in our study popula-
tion, further studies are required before this tech-
nique can be used to differentiate AF from SR in a
random population of horses.
Additional file
Additional file 1: Receiver Operating Curve (ROC) for the use of RMSSD
to distinguish atrial fibrillation from sinus rhythm in 14 warmblood horses
during a 2-min heart rate recording at rest, (A), walk (B) and trot (C). ECG-
man: RR intervals obtained from a surface ECG after manual correction of
QRS detection, using a commercial ECG software program (Televet 100
software version 5.1.2, Engel Engineering Services GmbH, Heusenstamm,
Germany) to calculate RMSSD within a commercial software program
(Kubios Heart Rate Variability Analysis Software, Varsitie 22, 70,150 Kuopio,
Finland). ECGaut: RR intervals after automatic analysis of the surface ECG
by a commercial ECG software program (Televet 100) to calculate RMSSD
within a commercial software program (Kubios Heart Rate Variability
Analysis Software). Five different levels of artifact correction were applied
for ECGaut, going from a very low to a very high level of filtering. HRM:
RR intervals obtained from a heart rate monitor (Polar heart rate sensor
H7, Polar Electro Benelux, Dendermonde, Belgium) using commercial
plastic electrodes (Polar equine heart rate electrode set, Polar Electro
Benelux, Dendermonde, Belgium) to calculate RMSSD within the
manufacturer’s software program (Polar Flow Software, Polar Electro
Benelux, Dendermonde, Belgium). (TIF 636 kb)
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